Friday, August 28, 2020

Johnson & Johnson's Janssen to begin Phase II COVID-19 vaccine trials next week in Spain

The trial will last two months and include 590 participants across the three countries, including 190 people in Spain, Illa told a news conference in Madrid.

from Economic Times https://ift.tt/2YK4tfz

No comments:

Post a Comment

Adani Group stocks slide up to 14% on US SEC heat

Adani Group stocks saw a sharp decline on Friday. This followed news that the US SEC is seeking court permission to email summons to founder...